{"id":2893,"date":"2019-09-18T06:00:00","date_gmt":"2019-09-18T06:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xps-sold-to-china\/"},"modified":"2019-09-18T06:00:00","modified_gmt":"2019-09-18T06:00:00","slug":"xps-sold-to-china","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/","title":{"rendered":"XPS\u2122 sold to China"},"content":{"rendered":"
XVIVO Perfusion has sold an XPS\u2122 to the second largest lung transplant clinic in China. The purpose is to start EVLP (Ex Vivo Lung Perfusion)-research at the CHINA-JAPAN FRIENDSHIP HOSPITAL in Beijing.<\/strong><\/div>\n

China is currently the fastest growing lung transplant market in the world, with a 35 % increase in lung transplants in 2018 (403 lung transplants performed). Due to the increased need for lung transplantation the number of clinics authorized to perform lung transplants has increased from 20 clinics in 2016 to 37 clinics in 2018. <\/span><\/p>\n

The lung transplant program lead by Professor JINGYU CHEN will head the EVLP program at the CHINA-JAPAN FRIENDSHIP HOSPITAL in Beijing. It is the second largest lung transplant clinic in China. They will investigate the effects of EVLP on Lung transplantation. The research intention is to evaluate EVLP in the clinical environment in China, which will add Chinese data to the existing EVLP data from North America and Europe. XVIVO Perfusion has initiated a registration process of the XPS\u2122 with the NMPA, the Chinese regulatory authority. In partnership with XVIVO Perfusion\u00b4s Distributor in China (<\/span>S<\/span>hanghai Genext Medical Technology Co., Ltd), the company plan to scientifically support the Lung transplant clinic of CHINA- JAPAN FRIENDSHIP HOSPITAL in Beijing.<\/span><\/p>\n

\u201cWe are very delighted that we delivered another XPS to a clinic in China. Considering the size of the population and the fast increase in the standard of living and healthcare, China is expected to become an important market for XVIVO in the near future\u201d, says Magnus Nilsson, CEO of XVIVO Perfusion. <\/span><\/p>\n

September 18, 2019<\/span><\/p>\n

Gothenburg
Magnus Nilsson, CEO<\/span><\/p>\n

XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

For further information please contact:<\/span><\/p>\n

Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com<\/span>
For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/p>\n

The information was submitted for publication, through the agency of the contact person set out above, at 8:00 a.m. CET on September 18, 2019.<\/span><\/p>\n

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion has sold an XPS\u2122 to the second largest lung transplant clinic in China. The purpose is to start…<\/p>\n","protected":false},"template":"","class_list":["post-2893","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn"],"acf":[],"yoast_head":"\nXPS\u2122 sold to China - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPS\u2122 sold to China - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion has sold an XPS\u2122 to the second largest lung transplant clinic in China. The purpose is to start...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sold-to-china\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sold-to-china\\\/\",\"name\":\"XPS\u2122 sold to China - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2019-09-18T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sold-to-china\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sold-to-china\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sold-to-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPS\u2122 sold to China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPS\u2122 sold to China - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/","og_locale":"en_US","og_type":"article","og_title":"XPS\u2122 sold to China - XVIVO","og_description":"XVIVO Perfusion has sold an XPS\u2122 to the second largest lung transplant clinic in China. The purpose is to start...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/","name":"XPS\u2122 sold to China - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2019-09-18T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sold-to-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XPS\u2122 sold to China"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}